ACHN - Thanks for your excellent CC notes. While I agree that it appeared that the results were being severely pumped (dietrich joking about Mount Sinai being used as a potential trial site may not have helped), it appeared that ACHN mainly had dietrich over to provide a different perspective. An impressive number of analysts from pretty much all the major firms called in and the first question was addressed to Dietrich so his presence was useful. I wonder though whether they would be able to get good terms when a potential partner knows that a next gen PI is waiting in the wings. It seems to me a potential partner would also want a part of a next gen compound in addition to the current one.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.